Roberta Bartolucci

3.4k total citations
17 papers, 532 citations indexed

About

Roberta Bartolucci is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Roberta Bartolucci has authored 17 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Roberta Bartolucci's work include Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Genetic factors in colorectal cancer (3 papers). Roberta Bartolucci is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Genetic factors in colorectal cancer (3 papers). Roberta Bartolucci collaborates with scholars based in Italy, Belgium and Spain. Roberta Bartolucci's co-authors include Laia Perez‐Roca, Pedro Méndez, Miquel Tarón, Imane Chaib, Raffaele Farabi, José Javier Sánchez, Francesco Puma, Paolo Magni, Francesco Di Costanzo and Marcin Skrzypski and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Radiology.

In The Last Decade

Roberta Bartolucci

16 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Bartolucci Italy 10 315 285 171 105 72 17 532
Jeanne Fourie Zirkelbach United States 11 267 0.8× 218 0.8× 122 0.7× 104 1.0× 46 0.6× 14 557
Hirokuni Ikeda Japan 10 205 0.7× 125 0.4× 195 1.1× 109 1.0× 62 0.9× 44 472
Patricia Tresca France 13 350 1.1× 190 0.7× 141 0.8× 127 1.2× 43 0.6× 26 542
Tahsin M. Khan United States 8 344 1.1× 364 1.3× 275 1.6× 115 1.1× 61 0.8× 23 604
Elisa Baldelli United States 13 212 0.7× 226 0.8× 339 2.0× 124 1.2× 48 0.7× 34 545
Woo Sun Kwon South Korea 16 401 1.3× 271 1.0× 267 1.6× 128 1.2× 56 0.8× 51 677
Itai Pashtan United States 11 164 0.5× 153 0.5× 166 1.0× 121 1.2× 54 0.8× 25 504
Elisa Caiola Italy 15 227 0.7× 164 0.6× 450 2.6× 208 2.0× 78 1.1× 33 621
Rossella Martinello Italy 13 431 1.4× 210 0.7× 134 0.8× 229 2.2× 33 0.5× 26 626
Shuta Ohara Japan 11 321 1.0× 405 1.4× 299 1.7× 108 1.0× 68 0.9× 37 627

Countries citing papers authored by Roberta Bartolucci

Since Specialization
Citations

This map shows the geographic impact of Roberta Bartolucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Bartolucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Bartolucci more than expected).

Fields of papers citing papers by Roberta Bartolucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Bartolucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Bartolucci. The network helps show where Roberta Bartolucci may publish in the future.

Co-authorship network of co-authors of Roberta Bartolucci

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Bartolucci. A scholar is included among the top collaborators of Roberta Bartolucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Bartolucci. Roberta Bartolucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bartolucci, Roberta, et al.. (2024). In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients. CPT Pharmacometrics & Systems Pharmacology. 13(3). 359–373. 6 indexed citations
2.
Ronchi, Diana De, et al.. (2023). Go beyond the limits of genetic algorithm in daily covariate selection practice. Journal of Pharmacokinetics and Pharmacodynamics. 51(2). 109–121. 6 indexed citations
3.
4.
Bartolucci, Roberta, Anne‐Gaëlle Dosne, Dénes Csonka, et al.. (2021). A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial Hypertension. Clinical Pharmacokinetics. 60(12). 1605–1619. 3 indexed citations
5.
6.
Bartolucci, Roberta, et al.. (2021). Application of Artificial Neural Networks to Predict the Intrinsic Solubility of Drug-Like Molecules. Pharmaceutics. 13(7). 1101–1101. 24 indexed citations
7.
Bartolucci, Roberta, Jia Wei, José Javier Sánchez, et al.. (2009). XPG mRNA Expression Levels Modulate Prognosis in Resected Non–Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 Expression. Clinical Lung Cancer. 10(1). 47–52. 53 indexed citations
8.
Rosell, Rafael, Marcin Skrzypski, Ewa Jassem, et al.. (2007). BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer. PLoS ONE. 2(11). e1129–e1129. 167 indexed citations
9.
Rinaldi, Monica, Lucio Crinò, Giorgio V. Scagliotti, et al.. (2000). A three-week schedule of gemcitabine–cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: A phase II randomized trial. Annals of Oncology. 11(10). 1295–1300. 46 indexed citations
10.
Gridelli, Cesare, Franco Perrone, Ciro Gallo, et al.. (1997). Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study. European Journal of Cancer. 33(3). 392–397. 77 indexed citations
11.
Costanzo, Francesco Di, et al.. (1996). Hydroxyurea May Increase the Activity of Fluorouracil plus Folinic Acid in Advanced Gastrointestinal Cancer: Phase II Study. Cancer Investigation. 14(3). 234–238. 6 indexed citations
12.
Costanzo, Francesco Di, Roberta Bartolucci, F. Calabresi, et al.. (1992). Original article: Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: A randomized trial of the Italian Oncology Group for Clinical Research (GOIRC). Annals of Oncology. 3(5). 371–376. 44 indexed citations
13.
Cocconi, Giorgio, Giancarlo Bisagni, M. Bacchi, et al.. (1991). Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research.. Journal of Clinical Oncology. 9(4). 664–669. 53 indexed citations
14.
Costanzo, Francesco Di, P Malacarne, S. Zironi, et al.. (1991). Preliminary report of high dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: A randomized trial of the italian oncology group for clinical research. Journal of Surgical Oncology. 48(S2). 137–140. 1 indexed citations
15.
Costanzo, Francesco Di, et al.. (1990). Thrombocytopenia following Treatment with Low Doses of Aminoglutethimide. Tumori Journal. 76(5). 511–512.
16.
Ciatto, Stefano, Stefano Cecchini, Anna Iossa, et al.. (1989). Association of estrogen receptors with parenchymal pattern at mammography.. Radiology. 170(3). 695–697. 5 indexed citations
17.
Costanzo, Francesco Di, et al.. (1988). High-Dose Folinic Acid and 5-Fluorouracil in Advanced Colorectal Cancer. Cancer Investigation. 6(2). 133–138. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeanne Fourie Zirkelbach Breakdown of academic impact, for papers by Hirokuni Ikeda Breakdown of academic impact, for papers by Patricia Tresca Breakdown of academic impact, for papers by Tahsin M. Khan Breakdown of academic impact, for papers by Elisa Baldelli Breakdown of academic impact, for papers by Woo Sun Kwon Breakdown of academic impact, for papers by Itai Pashtan Breakdown of academic impact, for papers by Elisa Caiola Breakdown of academic impact, for papers by Rossella Martinello Breakdown of academic impact, for papers by Shuta Ohara
Rankless by CCL
2026